Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Other Accumulated Expenses: 2024

  • Zhengye Biotechnology Holding's Other Accumulated Expenses was N/A to $20,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $20,000, marking a year-over-year change of. This contributed to the annual value of $20,000 for FY2024, which is N/A change from last year.
  • Latest data reveals that Zhengye Biotechnology Holding reported Other Accumulated Expenses of $20,000 as of Q4 2024.
  • In the past 5 years, Zhengye Biotechnology Holding's Other Accumulated Expenses ranged from a high of $20,000 in Q4 2024 and a low of $20,000 during Q4 2024.
  • Over the past 1 years, Zhengye Biotechnology Holding's median Other Accumulated Expenses value was $20,000 (recorded in 2024), while the average stood at $20,000.